0001237899-13-000064.txt : 20131217
0001237899-13-000064.hdr.sgml : 20131217
20131217160857
ACCESSION NUMBER: 0001237899-13-000064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131213
FILED AS OF DATE: 20131217
DATE AS OF CHANGE: 20131217
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YANCOPOULOS GEORGE
CENTRAL INDEX KEY: 0001226690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 131281944
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-12-13
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001226690
YANCOPOULOS GEORGE
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
Pres Regeneron Labs
Common Stock
2013-12-16
4
F
0
42974.0
272.73
D
1063638
D
Common Stock
5591
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
30.63
2013-12-13
4
A
0
150000.0
0.0
A
2020-12-14
Common Stock
150000
246736
D
Non-Qualified Stock Option (right to buy)
270.43
2013-12-13
4
A
0
203204.0
0.0
A
2023-12-13
Common Stock
203204
203204
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
On December 14, 2010, the reporting person was granted an option to purchase 150,000 shares of Common Stock. The option vests, partially or in full, on December 31, 2013, based on the extent to which the company satisfies certain performance criteria during the period ending December 31, 2013. The performance criteria have been met and the option will vest as to all 150,000 shares on December 31, 2013.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**George D. Yancopoulos
2013-12-17